Befunolol
![]() | |
| Systematic (IUPAC) name | |
|---|---|
|
(RS)-1-{7-[2-hydroxy-3-(propan-2-ylamino)propoxy]- 1-benzofuran-2-yl}ethanone | |
| Clinical data | |
| Trade names | Benfuran, Bentos, Betaclar, Glauconex |
| AHFS/Drugs.com | International Drug Names |
| Identifiers | |
| CAS Number |
39552-01-7 |
| ATC code | S01ED06 (WHO) |
| PubChem | CID 2309 |
| DrugBank |
DB09013 |
| ChemSpider |
2219 |
| UNII |
418546MT3A |
| KEGG |
D07496 |
| ChEMBL |
CHEMBL153984 |
| Chemical data | |
| Formula | C16H21NO4 |
| Molar mass | 291.342 g/mol |
| |
| |
| | |
Befunolol (INN) is a beta blocker with intrinsic sympathomimetic activity used in the management of open-angle glaucoma.[1] It also acts as a β adrenoreceptor partial agonist.[2][3] Befunolol was introduced in Japan in 1983 by Kakenyaku Kako Co. under the trade name Bentos.[4]
References
- ↑ Stephan Reichl, Christel C Müller-Goymann (2 January 2003). "The use of a porcine organotypic cornea construct for permeation studies from formulations containing befunolol hydrochloride". International Journal of Pharmaceutics 250 (1): 191–201. doi:10.1016/S0378-5173(02)00541-0.
- ↑ Koike, K; Takayanagi, I (October 1986). "A beta-adrenergic partial agonist (befunolol) discriminates two different affinity sites". Japanese Journal of Pharmacology 42 (2): 325–8. PMID 2879061.
- ↑ Takayanagi, I; Koike, K (January 1985). "A beta-adrenoceptor blocking agent, befunolol as a partial agonist in isolated organs". General Pharmacology: The Vascular System 16 (3): 265–267. doi:10.1016/0306-3623(85)90080-1.
- ↑ Pharmaceutical Manufacturing Encyclopedia (3rd revised ed.). Norwich, N.Y.: William Andrew Publishing. January 14, 2008. p. 542. ISBN 978-0815515265.
| ||||||||||||||||||||||||||||||||||||
This article is issued from Wikipedia - version of the Saturday, April 02, 2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.
